Publications by authors named "M R Holcomb"

The HIV-1 capsid is an irregularly shaped protein complex containing the viral genome and several proteins needed for integration into the host cell genome. Small molecules, such as the drug-like compound PF-3450074 (PF74) and the anionic sugar inositolhexakisphosphate (IP6), are known to impact capsid stability, although the mechanisms through which they do so remain unknown. In this study, we employed atomistic molecular dynamics simulations to study the impact of molecules bound to hexamers at the central pore (IP6) and the FG-binding site (PF74) on the interface between capsid oligomers.

View Article and Find Full Text PDF

Staphylococcus aureus () is an opportunistic human pathogen that causes over one million deaths around the world each year. We recently identified a family of serine hydrolases termed fluorophosphonate binding hydrolases (Fphs) that play important roles in lipid metabolism and colonization of a host. Because many of these enzymes are only expressed in bacteria, they are valuable targets for diagnostics and therapeutics.

View Article and Find Full Text PDF

Objective: To evaluate the implementation of a new streamlined service delivery model for cochlear implant (CI) patients at a mature academic CI program.

Setting: Tertiary referral center.

Patients: CI candidates and CI users.

View Article and Find Full Text PDF

Cosolvent molecular dynamics (MDs) are an increasingly popular form of simulations where small molecule cosolvents are added to water-solvated protein systems. These simulations can perform diverse target characterization tasks, including cryptic and allosteric pocket identification and pharmacophore profiling and supplement suites of enhanced sampling methods to explore protein conformational landscapes. The behavior of these systems is tied to the cosolvents used, so the ability to define diverse and complex mixtures is critical in dictating the outcome of the simulations.

View Article and Find Full Text PDF
Article Synopsis
  • * Nanomedicine, particularly through engineered nanoparticles (NPs), offers potential solutions for delivering therapies directly to affected brain areas, overcoming BBB challenges.
  • * The review highlights the classification of NPs into organic and inorganic types based on properties that affect drug delivery and monitoring, aiming to improve diagnosis and treatment outcomes for neurodegenerative diseases.
View Article and Find Full Text PDF